REF 1030241

EBV Quantification Kit

Quantitative detection of Epstein-Barr virus (EBV) DNA in peripheral blood, plasma, serum, throat swab, CSF and FFPE tissue specimens by real-time PCR.

IVD-D CE Quantitative UMS Compatible · Multiplex · 1-mix · 2-channel · 96-well · 24/48/96 reactions

Clinical Use

Quantitative detection of Epstein-Barr virus (EBV) DNA in nucleic acid extracts from peripheral blood, plasma, serum, throat swab, lymph node biopsy, CSF, urine and FFPE tissue specimens. Surveillance for post-transplant lymphoproliferative disorder (PTLD) following allogeneic haematopoietic stem cell transplantation, monitoring after solid organ transplantation and viral load follow-up in immunosuppressed patients.

Quantitative reporting is performed in copies/mL. Trend analysis (serial samples) is clinically more meaningful than a single absolute value.

Test Design

Target geneEBNA-1 (conserved region)
Internal controlRPP-30 (co-amplification on HEX/VIC channel)
Format1-mix mastermix · 2-channel readout (FAM, HEX)
Reaction volume10 µL total
Cycle time~50 min
Standard curve4-point, 10³ – 10⁶ copies/µL

Kit Contents (24-reaction pack)

Oligo Mix1 × 24 µL · primer + probe
Uniqplex Enzyme Mix1 × 120 µL
NTC1 × 1000 µL · negative control
Standards (4 points)4 × 50 µL · 10³ – 10⁶ copies/µL

48- and 96-reaction packs are also available — see IFU §3.

Validated Instruments

  • HiMedia InstaQ96
  • Bio-Rad CFX96 Touch
  • Applied Biosystems QuantStudio 5
  • Qiagen Rotor-Gene Q 5plex

Performance

The typical LoD is in the range of 50–500 copies/mL in extracted samples. The linear amplification range extends approximately 5–6 log₁₀ above the LoD. Cross-reactivity was tested against CMV, HSV 1/2, VZV, HHV-6/7/8 (including Kaposi-sarcoma HHV-8), BK virus, JC virus, Adenovirus, Parvovirus B19, HIV-1/2, Hepatitis B/C viruses and Toxoplasma gondii; no reactivity was observed. Kit-specific performance values are documented in the performance evaluation report.

Storage

Before use−20 °C · until expiry date
After opening−20 °C · 4 months (including freeze-thaw)
Freeze-thaw cycleMaximum 3

Regulatory

Class C IVD device. CE marked under the transitional provisions of Regulation (EU) 2017/746. The conformity assessment process under (EU) 2017/746 (IVDR) is ongoing. TİTCK registered. For in vitro diagnostic use only — for laboratory and professional use.